Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
Individualized neoantigen therapy could be ‘huge leap’ toward personalized medicine
A novel therapeutic approach stimulated new and existing T-cell responses among patients with melanoma or non-small cell lung cancer, according to results of a phase 1 trial.
Looking back, looking forward: Penn’s CAR-T program continues path of progress
In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center.
Log in or Sign up for Free to view tailored content for your specialty!
Revised criteria may ‘substantially reduce racial disparities’ in lung cancer screening
Alternative lung cancer screening criteria may identify more individuals, who would benefit from screening compared with current guidelines, study results showed.
‘Popularity paradox’: Evidence lacking to support lung cancer screening for never-smokers
Current evidence does not support lung cancer screening for never-smokers or former light smokers with a family history of lung cancer, according to a commentary in Journal of Thoracic Oncology.
Findings reveal ‘crucial’ need to manage immune checkpoint inhibitor-induced myocarditis
Patients with cancer who received immune checkpoint inhibitors rarely developed cardiovascular adverse events, according to results of a systematic review and meta-analysis.
Lung cancer radiotherapy exposes patients to arrhythmia risks based on factors such as dose
Exposure of certain cardiac structures to radiation during treatment of surgically inoperable or unresectable non-small cell lung cancer was associated with increased arrhythmia risk, researchers reported.
42% of nonsmokers have one or more solid lung nodules
A lung nodule sized 30 mm3 or greater was found in 42% of adults in Northern Europe who reported either never smoking or former smoking, according to results published in Radiology.
FDA approves first-line combination for EGFR-mutant non-small cell lung cancer
The FDA approved amivantamab-vmjw plus lazertinib as first-line treatment for certain adults with non-small cell lung cancer.
Indwelling pleural catheter for malignant pleural effusions reduces care costs
Twelve months after indwelling pleural catheter insertion vs. chemical pleurodesis for malignant pleural effusions, the average cost of health care was lower, according to results published in Annals of the American Thoracic Society.
Olanzapine reduces nausea, vomiting during moderately emetogenic chemotherapy
Olanzapine significantly reduced nausea and vomiting compared with observation for patients with solid tumors undergoing moderately emetogenic chemotherapy, according to results of a randomized phase 3 trial.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read